Viking Therapeutics: Strategic Growth and Strong Buy Rating Amidst Advancements in Obesity Drug Pipeline
Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...
Promising Clinical Developments and Strategic Initiatives Drive Buy Rating for Viking Therapeutics
BTIG analyst Justin Zelin reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...
MarketWatch21h
Natural Gas (NYM $/mmbtu) Front Month
2-Year U.S. Treasury Note Continuous Contract $102.742 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $106.242 0.078 0.07% 10-Year U.S. Treasury Note Continuous Contract $108.766 0.219 ...
Bloomberg L.P.19h
Novo Nordisk A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...